Gender Differences in the Vasomotor Effects of Different Steroid Hormones in Rat Pulmonary and Coronary Arteries

It is well recognised that oestrogens possess vasodilatory properties, and similar responses to testosterone have been demonstrated. However, vasomotor effects of other steroid hormones have not been well described. Direct comparisons of the relative vasoactivity of different steroid hormones in different vascular beds in male and female genders have not been made. Coronary and pulmonary arteries from adult Wistar rats were mounted in a wire myograph, loaded to 100 and 17 mmHg respectively, maximally pre-contracted with 1 × 10^-4 M prostaglandin-F-2-α, and dose response curves to 1 × 10^-6 to 1 × 10^-3 or 3 × 10^-3 M of 17β-oestradiol, testosterone, progesterone, and cortisol dissolved in water were constructed. Addition of each steroid hormone caused acute, dose dependent dilatation in coronary and pulmonary vessels. In coronary arteries the order of activity was testosterone > progesterone > 17β-oestradiol > cortisol, p < 0.001. In pulmonary arteries, the order of activity was progesterone > testosterone > cortisol > 17β-oestradiol, p < 0.001. Pulmonary arteries from male animals were more sensitive to the effects of testosterone than those from female animals, p = 0.003, whereas coronary arteries from female animals were more sensitive to the effects of 17β-oestradiol than those from male animals, p < 0.001. We have demonstrated significant differences in the in vitro vasomotor effects of different steroid hormones in two distinct vascular beds. Gender differences in vasomotor responses to steroid hormones may play a role in the aetiology of vasospastic diseases.

Vasoactive Agents - Arteries - Hormones - Vasodilatation - Rat

References

• 1 Farhat M Y, Abi-Younes S, Ramwell P W. Nongenomic effects of estrogen and the vessel wall.  Biochem Pharmacol. 1996;  51 571-576
• 2 Gilligan D M, Quyyumi A A, Cannon RO 3rd. Effects of physiological levels of estrogen on coronary vasomotor function in postmenopausal women.  Circulation. 1994;  89 (6) 2545-2551
• 3 Rosano G M, Peters N S, Lefroy D, Lindsay D C, Sarrel P M, Collins P, Poole-Wilson P A. 17-beta-Estradiol therapy lessens angina in postmenopausal women with syndrome X.  J Am Coll Cardiol. 1996;  28 (6) 1500-1505
• 4 Yue P, Chatterjee M B, Beale C, Poole-Wilson P A, Collins P. Testosterone relaxes rabbit coronary arteries and aorta.  Circulation. 1995;  91 1154-1160
• 5 Chou T M, Sudhir K, Hutchison S J, et al. Testosterone induces vasodilatation of canine coronary conductance and resistance arteries in vivo. .  Circulation. 1996;  94 2614-2619
• 6 Webb C M, McNeill J G, Hayward C S, de Zeigler D, Collins P. Effects of testosterone on coronary vasomotor regulation in men with coronary heart disease.  Circulation. 1999;  100 1690-1696
• 7 English K M, Steeds R P, Diver M J, Jones T H, Channer K S. Low dose transdermal testosterone therapy improves angina threshold in men with chronic stable angina.  Circulation. 2000;  102 (16) 1906-1912
• 8 Farrukh I S, Peng W, Orlinska U, Hoidal J R. Effect of dehydroepiandrosterone on hypoxic pulmonary vasoconstriction: a Ca²⁺ activated K⁺ channel opener.  Am J Physiol. 1998;  274 L186-L195
• 9 Mulvaney M J, Halpern W. Contractile properties of small arterial resistance vessels in spontaneously hypertensive and normotensive rats.  Circulat Res. 1977;  41 19-26
• 10 Porto C s, Lazari M FM, Abreu L C, Bardin C W, Gunsalas G L. Receptors for androgen binding proteins: Internalisation and intracellular signalling.  Journal of Steroid Biochemistry and Molecular Biology. 1995;  53 (1 - 6) 561-565
• 11 Thomas P, Dixon M S, Winterton S J, Sheridan D J. Acute haemodynamic effects of cromakalin in patients with angina pectoris.  Brit J Clin Pharmacol. 1990;  29 325-331
• 12 Bray K, Quast U. Differences in K⁺ channels opened by cromokalin, acetylcholine and Substance P in rat aorta and porcine coronary artery.  Brit J Pharmacol. 1991;  102 85-594
• 13 Rosano G M, Collins P, Kaski J C, Lindsay D C, Sarrel P M, Poole-Wilson P. Syndrome X in women is associated with oestrogen deficiency.  Eur Heart J. 1995;  16 (5) 610-614
• 14 Albertsson P A, Emanuelsson H, Milsom I. Beneficial effect of treatment with transdermal estradiol-17-beta on exercise induced angina and ST segment depression in syndrome X.  Int J Cardiol. 1996;  54 (1) 13-20
• 15 Wensel R, Opitz C F, Ewert R, Bruch L, Kleber F X. Effects of iloprost inhalation on exercise capacity and ventilatory efficiency in patients with primary pulmonary hypertension.  Circulation. 2000;  101 (20) 2388-2392
• 16 Kleiger R E, Boxer M, Ingham R E, Harrison D C. Pulmonary hypertension in patients using oral contraceptives. A report of six cases.  Chest. 1976;  69 (2) 143-147
• 17 Dawkins K D, Burke C M, Billingham M E, Jamieson S W. Primary pulmonary hypertension and pregnancy.  Chest. 1986;  89 383-388
• 18 Martinez J M, Comas C, Sala X, Gratacos E, Torres P J, Fortuny J. Maternal primary pulmonary hypertension associated with pregnancy.  Eur J Obstet Gynecol Reprod Biol. 1994;  54 (2) 143-147
• 19 Fuchs K I, Moore L G, Rounds S. Pulmonary vascular reactivity is blunted in pregnant rats.  J Appl Physiol. 1982;  53 (3) 703-707
• 20 Cutaia M, Friedrich P, Grimson R, Porcelli R J. Pregnancy- and gender-related changes in pulmonary vascular reactivity.  Exp Lung Res. 1987;  13 (3) 343-357
• 21 Silberstein S D, Merriam G R. Sex hormones and headache.  J Pain Symptom Manage. 1993;  8 (2) 98-114
• 22 Bartelink M L, Wollersheim H, van de Lisdonk E, Spruijt R, van Weel C. Prevalence of Raynaud’s phenomenon.  Neth J Med. 1992;  41 (3 - 4) 149-152
• 23 MacGregor E A. Menstruation, sex hormones, and migraine.  Neurol Clin. 1997;  15 (1) 125-141
• 24 Silberstein S D. The role of sex hormones in headache.  Neurology. 1992;  42 (3 Suppl. 2) 37-42
• 25 Greenstein D, Jeffcote N, Ilsley D, Kester R C. The menstrual cycle and Raynaud’s phenomenon.  Angiology. 1996;  47 (5) 427-436
• 26 Lafferty K, De Trafford J C, Potter C, Roberts V C, Cotton L T. Reflex vascular responses in the finger to contralateral thermal stimuli during the normal menstrual cycle: a hormonal basis to Raynaud’s phenomenon?.  Clin Sci. 1985;  68 (6) 639-645
• 27 Bartelink M L, Wollersheim H, Vemer H, Thomas C M, de Boo T, Thien T. The effects of single oral doses of 17 beta-oestradiol and progesterone on finger skin circulation in healthy women with primary Raynaud’s phenomenon.  Eur J Clin Pharmacol. 1994;  46 (6) 557-560